HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cindy Casteels Selected Research

MK-9470

8/201318F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cindy Casteels Research Topics

Disease

14Parkinson Disease (Parkinson's Disease)
10/2019 - 03/2006
6Neuroinflammatory Diseases
10/2019 - 10/2015
3Inflammation (Inflammations)
10/2019 - 12/2018
3Huntington Disease (Huntington's Disease)
12/2014 - 09/2010
2Stroke (Strokes)
01/2019 - 11/2012
2Dyskinesias (Dyskinesia)
01/2018 - 03/2012
2Epilepsy (Aura)
01/2016 - 06/2008
2Anorexia Nervosa
02/2014 - 03/2007
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020
1Cognitive Dysfunction
10/2019
1Synucleinopathies
10/2019
1Disease Progression
01/2019
1Ischemia
01/2019
1Gliosis
01/2019
1Cocaine-Related Disorders (Cocaine Addiction)
01/2018
1Hypercapnia
02/2017
1Schizophrenia (Dementia Praecox)
12/2015
1Fragile X Syndrome (Martin Bell Syndrome)
12/2015
1Tauopathies
06/2015
1Alcoholism (Alcohol Abuse)
02/2014
1Binge Drinking
02/2014
1Anorexia
02/2014
1Feeding and Eating Disorders (Eating Disorder)
02/2014
1Neoplasm Metastasis (Metastasis)
08/2013
1Carcinoma (Carcinomatosis)
08/2013
1Central Nervous System Diseases (CNS Diseases)
08/2010
1Parkinsonian Disorders (Parkinsonism)
03/2006
1Multiple System Atrophy
03/2006
1Essential Tremor (Essential Tremors)
03/2006
1Dementia (Dementias)
03/2006
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2006

Drug/Important Bio-Agent (IBA)

8Cannabinoid Receptors (Cannabinoid Receptor)IBA
10/2019 - 06/2008
5Oxidopamine (6 Hydroxydopamine)IBA
01/2018 - 11/2006
5EndocannabinoidsIBA
12/2014 - 06/2008
4N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
10/2019 - 10/2015
4CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2014 - 02/2010
3Levodopa (L Dopa)FDA LinkGeneric
10/2019 - 03/2012
3Glucose (Dextrose)FDA LinkGeneric
10/2019 - 01/2019
3alpha-SynucleinIBA
01/2019 - 03/2015
3LipopolysaccharidesIBA
12/2018 - 10/2015
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
02/2010 - 03/2006
1DNA-Binding Proteins (DNA Binding Protein)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Deoxyglucose (2 Deoxy D glucose)IBA
10/2019
1SynucleinsIBA
10/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Purinergic P2X7 ReceptorsIBA
01/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019
1Therapeutic UsesIBA
01/2019
1Glutamine (L-Glutamine)FDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2018
1ChloraloseIBA
02/2017
1Urethane (Ethyl Carbamate)IBA
02/2017
1Metabotropic Glutamate 5 ReceptorIBA
12/2015
1PrionsIBA
06/2015
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
12/2014
1Ethanol (Ethyl Alcohol)IBA
02/2014
1CannabinoidsIBA
02/2014
1MK-9470IBA
08/2013
1salicylhydroxamic acid (SHAM)IBA
11/2012
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2010
1Neuroprotective AgentsIBA
02/2007

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2018 - 03/2007
2Therapeutics
01/2016 - 08/2010
1Anesthesia
02/2017